Due to its crucial role in regulating cellular functions, p38 is currently being extensively studied as a drug target, and various inhibitors (Genovese, 2009) are being investigated for the treatment of diseases such as pain, asthma, cognitive impairment, RA, PD (Coulthard et al., 2009), cancer, myelodysplastic syndrome and depression (Johansen et al., 2005). This evidence concerns the gene MAPK14 and cancer.